Strangford MP Jim Shannon has thanked community pharmacists for their continued dedication during a visit to a Gordons Chemists in Newtownards.

John Clark, General Manager with Gordons Chemists welcomed Mr Shannon’s visit on Friday to highlight the important role local pharmacists played in the safe supply of medicines and provision of professional medical advice during the first wave of the pandemic.

The MP heard how community pharmacies remained open throughout the crisis to ensure that patients were supported even at the height of the pandemic.

Mr. Shannon also heard about the development of new and existing services in local community pharmacies such as the flu vaccination service, emergency supply of medicines, smoking cessation services and the minor ailments service.

Speaking at Gordons Chemist, Jim Shannon MP said:

“I was very pleased to visit Gordons Chemists in Newtownards today to thank John, Melissa and the team for their commitment and hard work during the pandemic.

“Community pharmacy teams have played a vital role in public health from the very beginning of the pandemic. They stood-up to the pandemic to provide primary care, ensuring essential medicines were delivered and access to healthcare was available to all within the community.

“The support provided by community pharmacies like Gordons will continue to be crucial as we move towards a second wave. Having these services available on our doorstep means the most vulnerable in our society can be cared for without having to attend their GP or other busy healthcare settings.

“The face-to-face nature of community pharmacy allows patients to know their pharmacy staff, making them feel safer and more cared for, especially in uncertain times like the pandemic. Our role now is to work with our community pharmacies to ensure they are supported in the long winter months.”

Melissa Ferguson Pharmacy Manager from Gordons Chemists said:

“We welcomed the opportunity to meet with Jim Shannon MP today and talk about community pharmacy’s response to this health crisis.

“The pandemic meant the day to day routines of our team needed to change, with longer hours, new services and the implementation of new procedures to protect both the public and our staff. Thanks to the dedication and commitment of our team, we were able to remain open for the duration of the first wave.

“Our team adapted quickly, understanding our role was to ensure the safe supply of medicines and advice to patients at all times, so that they could manage their conditions at home and keep further pressures away from our hospitals as much as possible.

“The winter months will mean a further demand of much needed community services including flu vaccination, which will be essential in protecting our NHS staff and the public. Therefore, careful planning and the continued accessibility of these services will be vital in the protection of the health and wellbeing of our communities this winter.”

The first UK conference was held recently for pharmacists to share learning and development through the COVID experience.

The digital event included contributions from community pharmacists in Northern Ireland which you can access below.


Community Pharmacist Stephen Slaine shares some of the adapations and solutions his pharmacy implemented to support the local community during COVID 19.

Community Pharmacist Joanne McMullan shares some of the adapations and solutions her pharmacy implemented to support the local community during COVID 19.

Community Pharmacist with Northern Pharmacies, Emma Kelly shares some of the adapations and solutions the pharmacy implemented to support the local community during COVID 19.

Community Pharmacist Eoghan O’Brien Community gives an insight into the role his pharmacy team had in supporting the health and wellbing of the local community during Covid 19

The Medicines and Healthcare products Regulatory Agency (MHRA) is changing the way it issues safety-critical alerts to healthcare providers.

From now on, all safety-critical alerts for medicines and medical devices that require action to be taken by healthcare organisations will be issued as National Patient Safety Alerts. These alerts follow criteria and a template agreed by the National Patient Safety Alerting Committee (NaPSAC).

This is to ensure that National Patient Safety alerts:

  • are only issued for safety-critical issues (those that have a risk of death or disability) that require organisations to act
  • explain risk clearly and effectively
  • have required actions that have been assessed for feasibility, safety, efficacy and cost-effectiveness
  • can be quickly recognised and actioned by senior personnel
  • have actions that are SMART (specific, measurable, achievable, realistic and timely)

All healthcare providers that currently receive medical device alerts and drug alerts should now ensure they subscribe to receive National Patient Safety Alerts.

Click here: For more info

The Department of Health has released updated information on the Serious Shortage Protocol (SSP) which was issued on 20th May 2020 in respect of fluoxetine 40mg capsules. The SSP was originally issued with an end date of Monday 20th July 2020, which was extended until 4th September 2020, 25th September 2020 and then until the 2nd October. The SSP has now been further extended until 16th October 2020. Details of the SSP are available on the BSO website and can be accessed via this link: www.hscbusiness.hscni.net/services/3063.htm

For August 2020, a concessionary price of £34.30 (per device) was granted for all generic prescriptions for ‘Adrenaline 150micrograms/0.15ml (1 in 1000) solution for injection pre-filled disposable devices’. This concessionary price will only apply to generically written prescriptions submitted for payment for the dispensing month of August. It is important to note that the concessionary price does NOT apply to any equivalent branded prescriptions issued for Jext® or Emerade® (note: Emerade® is currently unavailable as it was subject to a recent recall).

However, prescriptions for Jext 150mcg/0.15ml (1 in 1,000) solution for injection auto-injectors and Jext 300mcg/0.3ml (1 in 1,000) solution for injection auto-injectors will also be reimbursed at the price of £34.30 for August 2020 prescriptions. This is an exception and will help to avoid contractors dispensing these items (as branded prescriptions) at a loss during the month of August and also avoid the need for contractors to obtain replacement generically written prescriptions for accurate reimbursement.

A list of concessionary prices for September 2020 is available here.